Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression.
Ohrui
T
T
Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. ohrui@geriat.med.tohoku.ac.jp
Tomita
N
N
Sato-Nakagawa
T
T
Matsui
T
T
Maruyama
M
M
Niwa
K
K
Arai
H
H
Sasaki
H
H
D000368:Aged; D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects; D018450:Disease Progression; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D009483:Neuropsychological Tests; D011569:Psychiatric Status Rating Scales
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers